$126 Million is the total value of DAFNA Capital Management LLC's 95 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 41.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NXTM | Sell | NXSTAGE MEDICAL INC | $7,729,000 | +30.0% | 356,509 | -10.1% | 6.13% | +19.5% |
| ATRC | Buy | ATRICURE INC | $7,262,000 | -11.7% | 513,946 | +5.2% | 5.76% | -18.8% |
| VTAE | Sell | VITAE PHARMACEUTICALS INC | $7,123,000 | +36.5% | 660,188 | -16.2% | 5.64% | +25.4% |
| DERM | Buy | DERMIRA INC | $5,664,000 | +59.4% | 193,642 | +12.7% | 4.49% | +46.4% |
| ABBV | Sell | ABBVIE INC | $4,726,000 | -29.0% | 76,331 | -34.5% | 3.75% | -34.8% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $4,128,000 | +20.1% | 165,313 | +17.8% | 3.27% | +10.4% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $4,119,000 | +5.5% | 1,847,087 | -1.6% | 3.26% | -3.0% |
| NVAX | Sell | NOVAVAX INC | $3,999,000 | +40.0% | 550,000 | -0.6% | 3.17% | +28.6% |
| CYNA | Buy | CYNAPSUS THERAPEUTICS INC | $3,718,000 | +475.5% | 222,359 | +320.0% | 2.95% | +429.1% |
| GLPG | Sell | GALAPAGOS NVspon adr | $3,526,000 | +28.6% | 63,568 | -3.1% | 2.80% | +18.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $3,432,000 | +13.7% | 75,503 | -1.0% | 2.72% | +4.5% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $2,831,000 | +29.5% | 160,869 | -10.5% | 2.24% | +19.0% |
| PODD | Sell | INSULET CORP | $2,787,000 | -20.7% | 92,164 | -13.1% | 2.21% | -27.2% |
| TSRO | New | TESARO INC | $2,522,000 | – | 30,000 | +100.0% | 2.00% | – |
| LOXO | Buy | LOXO ONCOLOGY INC | $2,364,000 | +121.8% | 101,966 | +161.5% | 1.87% | +103.7% |
| AGTC | APPLIED GENETIC TECHNOL CORP | $2,362,000 | +1.1% | 167,192 | 0.0% | 1.87% | -7.1% | |
| TNDM | Buy | TANDEM DIABETES CARE INC | $2,358,000 | +641.5% | 312,756 | +755.7% | 1.87% | +582.1% |
| INSULET CORPnote 2.000% 6/1 | $2,294,000 | -1.5% | 2,407,000 | 0.0% | 1.82% | -9.6% | ||
| IMMU | New | IMMUNOMEDICS INC | $1,891,000 | – | 815,000 | +100.0% | 1.50% | – |
| ACHN | ACHILLION PHARMACEUTICALS | $1,845,000 | +1.0% | 236,500 | 0.0% | 1.46% | -7.2% | |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $1,703,000 | – | 350,392 | +100.0% | 1.35% | – |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $1,644,000 | 0.0% | 2,500,000 | 0.0% | 1.30% | -8.1% | ||
| BEAT | Sell | BIOTELEMETRY INC | $1,630,000 | -40.8% | 100,000 | -57.6% | 1.29% | -45.6% |
| ZGNX | Buy | ZOGENIX INC | $1,590,000 | +116.6% | 197,538 | +148.8% | 1.26% | +99.1% |
| BSTC | BIOSPECIFICS TECHNOLOGIES | $1,586,000 | +14.8% | 39,704 | 0.0% | 1.26% | +5.5% | |
| IBB | ISHARES TR NASDQ BIOTECetf | $1,544,000 | -1.3% | 6,000 | 0.0% | 1.22% | -9.3% | |
| SPNC | SPECTRANETICS CORP | $1,493,000 | +28.8% | 79,812 | 0.0% | 1.18% | +18.3% | |
| MGNX | MACROGENICS INC | $1,463,000 | +44.0% | 54,200 | 0.0% | 1.16% | +32.4% | |
| CYTK | Buy | CYTOKINETICS INC | $1,424,000 | +263.3% | 150,000 | +169.8% | 1.13% | +234.0% |
| DSCI | DERMA SCIENCES INC | $1,394,000 | +27.1% | 353,718 | 0.0% | 1.10% | +16.8% | |
| RDUS | Sell | RADIUS HEALTH INC | $1,382,000 | +3.2% | 37,600 | -11.7% | 1.10% | -5.2% |
| STXS | STEREOTAXIS INC | $1,345,000 | -10.9% | 1,372,862 | 0.0% | 1.07% | -18.2% | |
| CARA | CARA THERAPEUTICS INC | $1,284,000 | -22.7% | 267,046 | 0.0% | 1.02% | -29.0% | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $1,263,000 | -6.4% | 214,091 | +10.8% | 1.00% | -14.1% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,223,000 | +58.0% | 192,567 | +62.3% | 0.97% | +45.1% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $1,218,000 | -55.1% | 421,500 | +7.7% | 0.96% | -58.8% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS | $1,214,000 | +49.3% | 319,563 | +8.5% | 0.96% | +37.2% |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGS | $1,196,000 | – | 400,000 | +100.0% | 0.95% | – |
| AKAOQ | New | ACHAOGEN INC COM | $1,191,000 | – | 314,341 | +100.0% | 0.94% | – |
| QURE | UNIQURE B.V. | $1,171,000 | -38.0% | 158,907 | 0.0% | 0.93% | -43.0% | |
| JNJ | JOHNSON AND JOHNSON | $1,140,000 | +12.1% | 9,400 | 0.0% | 0.90% | +3.1% | |
| LDRH | Sell | LDR HLDG CORP | $1,109,000 | -13.5% | 30,000 | -40.4% | 0.88% | -20.5% |
| WINT | New | WINDTREE THERAPEUTICS INC | $1,029,000 | – | 533,358 | +100.0% | 0.82% | – |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $1,002,000 | -11.2% | 101,841 | 0.0% | 0.79% | -18.5% | |
| EXAC | EXACTECH INC | $846,000 | +32.0% | 31,636 | 0.0% | 0.67% | +21.3% | |
| NERV | New | MINERVA NEUROSCIENCES INC | $818,000 | – | 80,100 | +100.0% | 0.65% | – |
| ESSA PHARMA INC | $810,000 | +22.4% | 202,496 | 0.0% | 0.64% | +12.4% | ||
| GERN | New | GERON CORP | $764,000 | – | 285,000 | +100.0% | 0.61% | – |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $752,000 | – | 66,968 | +100.0% | 0.60% | – |
| ASND | ASCENDIS PHARMAsponsored adr | $707,000 | -28.4% | 53,241 | 0.0% | 0.56% | -34.3% | |
| ELOS | SYNERON MEDICAL LTD | $661,000 | +5.3% | 85,947 | 0.0% | 0.52% | -3.3% | |
| New | IRONWOOD PHARMACEUTICALS INCdbcv 2.250% 6/1 added | $620,000 | – | 600,000 | +100.0% | 0.49% | – | |
| BGNE | BEIGENE LTDsponsored adr added | $596,000 | +1.7% | 20,000 | 0.0% | 0.47% | -6.5% | |
| SCYX | Buy | SCYNEXIS INC | $579,000 | -8.4% | 266,904 | +70.1% | 0.46% | -15.8% |
| CYNAPSUS THERAPEUTICS INC | $564,000 | +35.6% | 33,995 | 0.0% | 0.45% | +24.5% | ||
| INNL | New | INNOCOLL HLDGS PLC | $551,000 | – | 100,000 | +100.0% | 0.44% | – |
| INTEC PHARMA LTD JERUSALEM | $549,000 | +11.8% | 119,296 | 0.0% | 0.44% | +2.6% | ||
| TARGACEPT INCnote 2/1 | $531,000 | 0.0% | 530,821 | 0.0% | 0.42% | -8.1% | ||
| MASI | Sell | MASIMO CORPORATION | $525,000 | -72.7% | 10,000 | -78.3% | 0.42% | -75.0% |
| BLUE | BLUEBIRD BIO INC | $519,000 | +1.8% | 12,000 | 0.0% | 0.41% | -6.6% | |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $446,000 | – | 103,690 | +100.0% | 0.35% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $444,000 | – | 140,600 | +100.0% | 0.35% | – |
| ABEO | ABEONA THERAPEUTICS INC | $429,000 | -7.7% | 181,818 | 0.0% | 0.34% | -15.2% | |
| VTVT | VTV THERAPEUTICS INCcl a | $423,000 | +12.2% | 73,000 | 0.0% | 0.34% | +3.1% | |
| NEOS | NEOS THERAPEUTICS INC | $361,000 | -13.8% | 38,873 | 0.0% | 0.29% | -20.8% | |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $360,000 | +278.9% | 223,325 | +344.7% | 0.28% | +247.6% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $358,000 | -44.6% | 119,300 | -1.1% | 0.28% | -49.0% |
| CGNT | COGENTIX MEDICAL INC | $339,000 | -12.6% | 352,882 | 0.0% | 0.27% | -19.7% | |
| ARDX | Sell | ARDELYX INC | $262,000 | -76.0% | 30,000 | -78.6% | 0.21% | -77.9% |
| ABUS | Sell | ARBUTUS BIOPHARMA CORP | $261,000 | -45.2% | 75,000 | -34.9% | 0.21% | -49.6% |
| NMUS | Sell | NEMUS BIOSCIENCE INC | $252,000 | -37.0% | 511,508 | -11.9% | 0.20% | -42.0% |
| DXTRQ | New | DEXTERA SURGICAL INC | $252,000 | – | 140,275 | +100.0% | 0.20% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $249,000 | – | 259,067 | +100.0% | 0.20% | – |
| Buy | NEURODERM LTD | $234,000 | +1276.5% | 14,421 | +1099.8% | 0.18% | +1133.3% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $232,000 | +1.3% | 423,336 | 0.0% | 0.18% | -7.1% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $205,000 | – | 10,100 | +100.0% | 0.16% | – |
| GLYC | New | GLYCOMIMETICS INC | $204,000 | – | 27,996 | +100.0% | 0.16% | – |
| TENX | TENAX THERAPEUTICS INC | $204,000 | +25.2% | 79,509 | 0.0% | 0.16% | +14.9% | |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $203,000 | -71.6% | 24,955 | -71.7% | 0.16% | -73.9% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $185,000 | -68.8% | 24,700 | -62.4% | 0.15% | -71.2% |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $183,000 | – | 46,900 | +100.0% | 0.14% | – |
| CASC | New | CASCADIAN THERAPEUTICS INC | $165,000 | – | 175,000 | +100.0% | 0.13% | – |
| CHEK | Sell | CHECK CAP LTD | $123,000 | -49.8% | 88,220 | -1.1% | 0.10% | -54.0% |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $115,000 | -96.2% | 90,237 | -84.1% | 0.09% | -96.5% |
| CBIO | CATALYST BIOSCIENCES INC | $108,000 | -9.2% | 70,903 | 0.0% | 0.09% | -16.5% | |
| NVLS | NIVALIS THERAPEUTICS INC | $69,000 | +9.5% | 15,000 | 0.0% | 0.06% | +1.9% | |
| CVM | CEL SCI CORP | $59,000 | -13.2% | 127,482 | 0.0% | 0.05% | -20.3% | |
| GNVC | GENVEC INC | $55,000 | -28.6% | 95,800 | 0.0% | 0.04% | -33.3% | |
| ATRS | ANTARES PHARMA INC | $47,000 | +20.5% | 45,000 | 0.0% | 0.04% | +8.8% | |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $14,000 | -98.1% | 2,499 | -98.6% | 0.01% | -98.3% |
| ETRM | ENTEROMEDICS INC COM PAR 0.01 | $10,000 | -68.8% | 33,334 | 0.0% | 0.01% | -71.4% | |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $6,000 | -90.9% | 458 | -90.3% | 0.01% | -91.2% |
| CHEKW | Sell | CHECK CAP LTD*w exp 02/28/202 | $5,000 | -88.1% | 53,488 | -0.4% | 0.00% | -88.9% |
| ONTX | New | ONCONOVA THERAPEUTICS INC | $1,000 | – | 200 | +100.0% | 0.00% | – |
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -13,488 | -100.0% | -0.06% | – |
| DNAI | Exit | PRONAI THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.06% | – |
| BPMX | Exit | BIOPHARMX CORP | $0 | – | -146,800 | -100.0% | -0.14% | – |
| AFMD | Exit | AFFIMED THERAPEUTICS BV | $0 | – | -46,701 | -100.0% | -0.15% | – |
| STEM | Exit | STEMCELLS INC | $0 | – | -699,563 | -100.0% | -0.16% | – |
| APPY | Exit | VENAXIS INC | $0 | – | -74,350 | -100.0% | -0.17% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -149,642 | -100.0% | -0.36% | – |
| Exit | ENDOLOGIX INCnote 3.250%11/0 added | $0 | – | -500,000 | -100.0% | -0.43% | – | |
| CRDC | Exit | CARDICA INC COM | $0 | – | -140,275 | -100.0% | -0.43% | – |
| Exit | IRONWOOD PHARMAnote 2.25% 15-jun-2022 144a sr unsecured conv | $0 | – | -600,000 | -100.0% | -0.47% | – | |
| EDGE | Exit | EDGE THERAPEUTICS INC | $0 | – | -69,177 | -100.0% | -0.55% | – |
| TBRA | Exit | TOBIRA THERAPEUTICS INC | $0 | – | -81,402 | -100.0% | -0.58% | – |
| CDNA | Exit | CAREDX INC | $0 | – | -136,047 | -100.0% | -0.58% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -47,500 | -100.0% | -0.59% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -140,600 | -100.0% | -0.63% | – |
| DSCO | Exit | DISCOVERY LABORATORIES INC N COM PAR | $0 | – | -533,358 | -100.0% | -0.77% | – |
| MNOV | Exit | MEDICINOVA INC | $0 | – | -125,000 | -100.0% | -0.79% | – |
| LPCN | Exit | LIPOCINE INC | $0 | – | -95,731 | -100.0% | -0.84% | – |
| CYAD | Exit | CELYADadr | $0 | – | -30,000 | -100.0% | -1.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.